Clinical Trials Logo

Clinical Trial Summary

Cerebral venous sinus thrombosis (cvst) is an underdiagnosed neurological condition with variable clinical presentations and variable risk factors CVST is often an underdiagnosed cause of acute or slowly progressive neurological deficit. With increasing awareness of the entity and easy accessibility to the non-invasive test like CT and MRI scans,CVST cases are now being diagnosed more frequently and it is now thought to occur more commonly than previously is also probably true that this condition is more frequent in underdeveloped countries

Clinical Trial Description


Study Design

Related Conditions & MeSH terms

NCT number NCT05211102
Study type Observational
Source Assiut University
Status Not yet recruiting
Start date May 1, 2022
Completion date June 1, 2023

See also
  Status Clinical Trial Phase
Completed NCT04569279 - Rivaroxaban vs. Warfarin in CVT Treatment Phase 3
Recruiting NCT03778502 - DOAC in Unusual Site Venous Thrombosis
Completed NCT02585713 - Apixaban or Dalteparin in Reducing Blood Clots in Patients With Cancer Related Venous Thromboembolism Phase 3
Active, not recruiting NCT03329365 - Paroxysmal Nocturnal Hemoglobinuria in ESUS & ETUS
Active, not recruiting NCT03080883 - Apixaban in Preventing Secondary Cancer Related Venous Thrombosis in Cancer Patients Who Have Completed Anticoagulation Therapy Phase 3
Recruiting NCT05021198 - The Norwegian Cerebral Venous Thrombosis Study
Completed NCT05448248 - Multicenter Registry Study Of Cerebral Venous Thrombosis In China (RETAIN-CH)